Perhaps then, the term “gluten-sensitive IgA/neutrophil-mediated dermatitis” (the acronym GAND would sound nicely) suggested by us for the dermatosis described by Louis Adolphus Duhring would be more understandable for non-dermatologic medical/pharmaceutical/biotechnological community and lay public alike (6). This evidence concerns the gene CD79A and skin disorder.